Search

Breast cancer (BC) is currently the most common form of cancer diagnosed worldwide with an incidence estimated at 2.26 million in 2020. Additionally, BC is the leading cause of cancer death. Many subtypes of breast cancer exist with distinct biological features and which respond differently to various treatment modalities and have different clinical outcomes. To ensure that sufferers receive lifesaving patients-tailored treatment early, it is crucial to accurately distinguish dangerous malignant (ductal carcinoma, lobular carcinoma, mucinous carcinoma, and papillary carcinoma) subtypes of tumors from adenosis, fibroadenoma, phyllodes tumor, and tubular adenoma benign harmless subtypes. An excellent automated method for detecting malignant subtypes of tumors is desirable since doctors do not identify 10% to 30% of breast cancers during regular examinations. While several computerized methods for breast cancer classification have been proposed, deep convolutional neural networks (DCNNs) have demonstrated superior performance. In this work, we proposed an ensemble of four variants of DCNNs combined with the support vector machines classifier to classify breast cancer histopathological images into eight subtypes classes: four benign and four malignant. The proposed method utilizes the power of DCNNs to extract highly predictive multi-scale pooled image feature representation (MPIFR) from four resolutions (40×, 100×, 200×, and 400×) of BC images that are then classified using SVM. Eight pre-trained DCNN architectures (Inceptionv3, InceptionResNetv2, ResNet18, ResNet50, DenseNet201, EfficientNetb0, shuffleNet, and SqueezeNet) were individually trained and an ensemble of the four best-performing models (ResNet50, ResNet18, DenseNet201, and EfficientNetb0) was utilized for feature extraction. One-versus-one SVM classification was then utilized to model an 8-class breast cancer image classifier. Our work is novel because while some prior work has utilized CNNs for 2- and 4-class breast cancer classification, only one other prior work proposed a solution for 8-class BC histopathological image classification. A 6B-Net deep CNN model was utilized, achieving an accuracy of 90% for 8-class BC classification. In rigorous evaluation, the proposed MPIFR method achieved an average accuracy of 97.77%, with 97.48% sensitivity, and 98.45% precision on the BreakHis histopathological BC image dataset, outperforming the prior state-of-the-art for histopathological breast cancer multi-class classification and a comprehensive set of DCNN baseline models. [ABSTRACT FROM AUTHOR]

Breast cancer accounts for 30% of all female cancers. Accurately distinguishing dangerous malignant tumors from benign harmless ones is key to ensuring patients receive lifesaving treatments on time. However, as doctors currently do not identify 10% to 30% of breast cancers during regular assessment, automated methods to detect malignant tumors are desirable. Although several computerized methods for breast cancer classification have been proposed, convolutional neural networks (CNNs) have demonstrably outperformed other approaches. In this paper, we propose an automated method for the binary classification of breast cancer tumors as either malignant or benign that utilizes a bag of deep multi-resolution convolutional features (BoDMCF) extracted from histopathological images at four resolutions (40×, 100×, 200× and 400×) by three pre-trained state-of-the-art deep CNN models: ResNet-50, EfficientNetb0, and Inception-v3. The BoDMCF extracted by the pre-trained CNNs were pooled using global average pooling and classified using the support vector machine (SVM) classifier. While some prior work has utilized CNNs for breast cancer classification, they did not explore using CNNs to extract and pool a bag of deep multi-resolution features. Other prior work utilized CNNs for deep multi-resolution feature extraction from chest X-ray radiographs to detect other conditions such as pneumoconiosis but not for breast cancer detection from histopathological images. In rigorous evaluation experiments, our deep BoDMCF feature approach with global pooling achieved an average accuracy of 99.92%, sensitivity of 0.9987, specificity (or recall) of 0.9797, positive prediction value (PPV) or precision of 0.99870, F1-Score of 0.9987, MCC of 0.9980, Kappa of 0.8368, and AUC of 0.9990 on the publicly available BreaKHis breast cancer image dataset. The proposed approach outperforms the prior state of the art for histopathological breast cancer classification as well as a comprehensive set of CNN baselines, including ResNet18, InceptionV3, DenseNet201, EfficientNetb0, SqueezeNet, and ShuffleNet, when classifying images at any individual resolutions (40×, 100×, 200× or 400×) or when SVM is used to classify a BoDMCF extracted using any single pre-trained CNN model. We also demonstrate through a carefully constructed set of experiments that each component of our approach contributes non-trivially to its superior performance including transfer learning (pre-training and fine-tuning), deep feature extraction at multiple resolutions, global pooling of deep multiresolution features into a powerful BoDMCF representation, and classification using SVM. [ABSTRACT FROM AUTHOR]

This paper presents an implantable polymer/metal alloy thin film structure for localized post-operative treatment of breast cancer. A combination of experiments and models is used to study the temperature changes due to Joule heating by patterned metallic thin films embedded in polydimethylsiloxane. The heat conduction within the device and the surrounding normal/cancerous breast tissue is modeled with three-dimensional finite element method (FEM). The FEM simulations are used to explore the potential effects of device geometry and Joule heating on the temperature distribution and lesion (thermal dose). The FEM model is validated using a gel model that mimics biological media. The predictions are also compared to prior results from in vitro studies and relevant in vivo studies in the literature. The implications of the results are discussed for the potential application of polymer/metal thin film structures in hyperthermic treatment of cancer. [ABSTRACT FROM AUTHOR]

For early-stage breast cancers mastectomy is an aggressive form of treatment. Therefore, there is a need for new treatment strategies that can enhance the use of lumpectomy by eliminating residual cancer cells with limited side effects to reduce local recurrence. Although, various radiotherapy-based methods have been developed, residual cells are found in 20–55% of the time at the first operation. Furthermore, some current treatment methods result in poor cosmesis. For the last decade, the authors have been exploring the use of polymeric composite materials in single and multi-modal implantable biomedical devices for post-operative treatment of breast cancer. In this paper, the concept and working principles of the devices, as well as selected results from experimental and numerical investigations, are presented. The results show the potential of the biomedical implants for cancer treatment. [ABSTRACT FROM AUTHOR]